| Authorised form of name | Eaves; Connie Jean (1944-2024); cancer biologist |
| Other forms of name | Constance |
| Dates | 1944 - 2024 |
| Nationality | Canadian |
| Place of birth | Ottawa, Ontario, Canada |
| Date of birth | 22/05/1944 |
| Date of death | 7 March 2024 |
| Occupation | cancer biologist |
| Research field | Medical genetics |
| Stem cells |
| Cancer |
| Cancer genetics |
| Activity | Education:
Queen's University (BA), (MS); University of Manchester (PhD)
Career:
Moved to Vancouver and became the second research scientist to be hired to the staff of the BC Cancer Institute (1981-2023); founded the Terry Fox Laboratory with ther husband (1981), British Columbia Cancer Research Institute; University Professor, Departments of Medical Genetics, Medicine, Pathology & Laboratory Medicine, and the School of Biomedical Engineering, University of British Columbia, Canada.
Awards/Medals:
Royal Society of Canada 2008
Robert. L. Noble Prize for Excellence in Cancer Research from the National Cancer Institute of Canada 2003
Donald Metcalf Lecture Award by the International Society for Experimental Hematology 2008
Canadian Blood Services' 2011 Lifetime Achievement Award 2011
Corresponding Fellow of the Royal Society of Edinburgh 2105
Dr. Chew Wei Memorial Prize in Cancer Research from the University of British Columbia's Faculty of Medicine 2016
American Society of Hematology's E. Donnall Thomas Prize 2018
Tobias Award from the International Society for Stem Cell Research 2018
Canada Gairdner Wightman Award 2019
Inductee, Canadian Medical Hall of Fame 2019
Officer Order of Canada 2021
Memberships:
Fellow of the Royal Society of Canada 1994
Fellow of the Royal Society of Edinburgh 2015 |
| Membership category | Fellow |
| Date of election | 21/04/2021 |
| Age at election | 76 |
| Relationships | Spouse: Dr. Allen Eaves
Children: Four. |
| OtherInfo | Recognised for her development of robust functional methods to quantify and characterise distinct types of primitive blood and mammary cell precursors - now considered gold standards. Their use has enabled many discoveries, including Dr Eaves' first demonstration with her husband of quiescent malignant stem cells in chronic myeloid leukemia. Her group exploited new ways of prospectively analysing the process of human leukemia and breast cancer development from genetically engineered normal human cells. |
| Source | Sources:
Fellows Directory, Dr Connie Eaves FRS, on The Royal Society website [URL: https://royalsociety.org/people/connie-eaves-35013/; last accessed: 05/12/2024]
BC Cancer website [URL: http://www.bccancer.bc.ca/about/news-stories/stories/in-memorium-remembering-dr-connie-eaves-a-world-renowned-pioneer-in-stem-cell-research1; last accessed: 05/12/2024] |
| Code | NA10371 |
Archives associated with this Fellow
| RefNo | Title | Date |
| EC/2021/12 | Eaves, Connie J: certificate of election to the Royal Society | 21 April 2021 |